Gal Bitan, Ph.D.

Gal Bitan, Ph.D.

Professor In-Residence, Neurology Member, Biochemistry, Biophysics & Structural Biology GPB Home Area Brain Research Institute Molecular Pharmacology GPB Home Area Neuroscience GPB Home Area


310-206 2082

635 Charles E Young Drive South
Los Angeles, CA 90095
UNITED STATES


Biography

Gal Bitan got his PhD in organic chemistry from the Hebrew University of Jerusalem, Israel. Dr. Bitan’s graduate work on unnatural amino acids and non-conventional peptide cyclization methodologies led him to postdoctoral studies on the structural biology of ligand-receptor systems including integrins and G protein-coupled receptors at Clark University, Worcester, MA and Beth Israel-Deaconess Medical Center/Harvard Medical School, Boston, MA. Dr. Bitan then moved on to tackle the problem of protein misfolding and aggregation, which is involved in over 30 devastating diseases, such as Alzheimer’s disease, Parkinson’s disease, prion diseases (e.g., Mad Cow disease), amyotrophic lateral sclerosis (Lou Gherig’s disease), and type II diabetes. Working at Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, Dr. Bitan has made fundamental contributions to the study of early events in the pathologic cascades that cause Alzheimer’s disease. In Alzheimer’s disease, the amyloid ß-protein (Aß) self-associates to form a variety of oligomeric and polymeric structures with potent neurotoxic activities. In particular, Aß oligomers have been implicated as the probable cause of Alzheimer’s disease. Dr. Bitan introduced the use of novel photochemical protein cross-linking techniques for investigation of Aß assembly and discovered one of the earliest oligomers in the assembly cascade, the paranucleus. In 2004, Dr. Bitan joined UCLA where he is currently a Professor of Neurology. His research program is focused on translational science geared at developing novel, mechanism-based diagnostic and therapeutic tools for neurodegenerative diseases, including Alzheimer’s disease and other tauopathies, Parkinson’s disease, multiple system atrophy, and amyotrophic lateral sclerosis.

Awards and Honors

  • Invited Plenary Lecture Asilomar Conference on Neurodegenerative Diseases, American Society for Mass Spectrometry, 2021.
  • Invited Keynote Speaker of Annual Symposium, The MSA Coalition, 2021.
  • Inaugural Undergraduate Faculty Mentor Award, UCLA, 2018.
  • Turken Award for Alzheimer’s Disease Research, UCLA, 2005.

Publications